ISRCTN ISRCTN61835374
DOI https://doi.org/10.1186/ISRCTN61835374
Protocol serial number N0274181493
Sponsor University Hospitals of Leicester NHS Trust (UK)
Funder West Suffolk Hospitals NHS Trust (UK), NHS R&D Support Funding
Submission date
28/09/2007
Registration date
28/09/2007
Last edited
16/01/2014
Recruitment status
Stopped
Overall study status
Stopped
Condition category
Ear, Nose and Throat
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Mr Carl Philpott
Scientific

St Paul's Sinus Centre
St Paul's Hospital
1081 Burrard Street
Vancouver, BC
V6Z 1Y6
Canada

Phone +1 604 806 9926
Email carl.philpott@btinternet.com

Study information

Primary study designInterventional
Study designRandomised controlled trial
Secondary study designRandomised controlled trial
Study type Participant information sheet
Scientific title
Study objectivesThe aim of this study is to evaluate the whether pheromones can influence the occurrence of superosmia during an olfactory threshold test.
Ethics approval(s)Added September 2008: UCLH Committee (UK), ref 06/Q0505/10, 04/08/06 (Ethics Approval), 18/05/07 (R&D Approval).
Health condition(s) or problem(s) studiedEar, Nose and Throat: Superosmia
InterventionThe study will take place at the ENT departments of Leicester Royal Infirmary and the West Suffolk Hospital. One hundred subjects will be recruited from amongst hospital staff who consider themselves to have a 'normal' sense of smell and no active sino-nasal disease. The study will take the form of a single-blinded randomised controlled trial. Subjects selected will be invited to undergo a 15 minute smell test and examination of their nose. They will be tested with a computer-driven olfactometer which enables a quantitative threshold test to be performed for several odours: phenethyl alcohol (roses), eucalyptol (menthol), acetic acid (vinegar) and mercaptan (gas). These odours have been shown to represent distinct entities in an individual’s sense of smell (1) and the test format has been validated in our previous work (2). The test involves the patient being seated in front of the olfactometer and the process of the test is explained to them by the researcher. At the voice prompts from the computer attached to the olfactometer, they will be asked to deliver two puffs of air from the spout using the two buttons attached to the olfactometer’s valve. The puffs of air are paired, one being a blank, the other containing the odour and they will be asked to identify the odour repeatedly like this in a forced response format until they have defined a threshold.

Following this they will then be exposed to either a pheromone (delta4,16-androstadien-3-one for female subjects and 1,3,5,(10),16-estratetraen-3-ol for male subjects) or sterile water - 1cm3 of the solution will be placed on a mask and held in front of the subjects nose for 2 minutes. The substance applied to the mask will be determined by use of a closed envelope system. Subjects will be then retested for their olfactory thresholds using the technique described above. This whole process will take less than an hour and no further involvement will be required of the individual subjects.

1. Gaskin JA, Robinson A, Philpott CM, Goodenough PC, Murty GE. Are patients cross-sensitive to odours in parallel threshold tests Chemical Senses 2006
2. Philpott CM, Dhanji F, Wolstenholme CR, Goodenough PC, Clark A, Murty GE. Eucalyptol olfactory threshold testing with a computer driven olfactometer. Journal of Laryngology and Otology 2006

Updated 16/01/2014: The study did not proceed due to a lack of funds and personnel.
Intervention typeDrug
PhaseNot Specified
Drug / device / biological / vaccine name(s)pheromones
Primary outcome measure(s)

Olfactory thresholds

Key secondary outcome measure(s)

No secondary outcome measures

Completion date01/08/2009
Reason abandoned (if study stopped)Lack of funding/sponsorship

Eligibility

Participant type(s)Patient
Age groupNot Specified
SexAll
Target sample size at registration100
Key inclusion criteriaAnyone who considers themselves to have a normal sense of smell.
Key exclusion criteriaPeople who are found to be hyposmic/anosmic (ie lacking in ability to detect odours at normal levels), people with sino-nasal disease, people unable to understand spoken English or who are mentally impaired.
Date of first enrolment11/08/2008
Date of final enrolment01/08/2009

Locations

Countries of recruitment

  • United Kingdom
  • Canada

Study participating centre

St Paul's Sinus Centre
Vancouver, BC
V6Z 1Y6
Canada

Results and Publications

Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Participant information sheet Participant information sheet 11/11/2025 11/11/2025 No Yes